Additionally, the C47T polymorphism in the gene encoding superoxide dismutase 2 (SOD2) has been associated with reduced SOD2 activity, elevated ROS levels, and an increased risk of NASH development and advanced fibrosis in NAFLD. This evidence concerns the gene SOD2 and metabolic dysfunction-associated steatohepatitis.